| 000 | 01602 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250517181503.0 | ||
| 264 | 0 | _c20180622 | |
| 008 | 201806s 0 0 eng d | ||
| 022 | _a1791-3004 | ||
| 024 | 7 |
_a10.3892/mmr.2017.7742 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhou, Meng-Qiao | |
| 245 | 0 | 0 |
_aDihydromyricetin protects against lipopolysaccharide‑induced cardiomyocyte injury through the toll‑like receptor‑4/nuclear factor‑κB pathway. _h[electronic resource] |
| 260 |
_bMolecular medicine reports _cDec 2017 |
||
| 300 |
_a8983-8988 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCardiotonic Agents _xpharmacology |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aFlavonols _xpharmacology |
| 650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
| 650 | 0 | 4 |
_aInflammation _xgenetics |
| 650 | 0 | 4 |
_aInflammation Mediators _xmetabolism |
| 650 | 0 | 4 | _aLipopolysaccharides |
| 650 | 0 | 4 |
_aMyocytes, Cardiac _xdrug effects |
| 650 | 0 | 4 |
_aNF-kappa B _xmetabolism |
| 650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aToll-Like Receptor 4 _xmetabolism |
| 700 | 1 | _aShao, Ling | |
| 700 | 1 | _aWu, Jing | |
| 700 | 1 | _aPeng, Na | |
| 700 | 1 | _aJin, Lu-Ping | |
| 700 | 1 | _aWei, Guo-Zhen | |
| 700 | 1 | _aCheng, Wei | |
| 700 | 1 | _aDeng, Chang-Jin | |
| 773 | 0 |
_tMolecular medicine reports _gvol. 16 _gno. 6 _gp. 8983-8988 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3892/mmr.2017.7742 _zAvailable from publisher's website |
| 999 |
_c27692107 _d27692107 |
||